A trial looking at carboplatin and etoposide with thalidomide for small cell lung cancer

This trial looked at adding thalidomide to carboplatin and etoposide. It was for people who had small cell lung cancer. This trial was supported by Cancer Research UK.

Thalidomide is a type of biological therapy. It stops the cancer forming new blood vessels. All cells need a blood supply to be able to grow.

Carboplatin and etoposide are types of chemotherapy. They are already used to treat small cell lung cancer.

The aims of this trial were to see

• If the combination of carboplatin, etoposide and thalidomide is useful for treating small cell lung cancer

• What the side effects are